JESSICA MASTBERGEN: Open Payments
NPI 1023501699 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 12 payments from 11 companies in 2025. Trend: 2023 $305 · 2024 $245 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 1 | $71 |
| Novo Nordisk Inc | 2 | $38 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Seqirus USA Inc | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: t:slim X2 Insulin Pump with Control-IQ, TRELEGY ELLIPTA, SPRAVATO, TZIELD, SOMAVERT, Fluad, UBRELVY, Ozempic.
Industry payments across MI — which companies pay providers there.
